BTIG Healthcare Investment Banking Adds Doug Kleinberg to Bolster Corporate Client Coverage
New York – May 20, 2021 – BTIG announced today that Doug Kleinberg has joined its Healthcare Investment Banking unit as a Managing Director. At BTIG, Mr. Kleinberg will focus on investment banking opportunities for corporate clients across biotech, biopharma and pharma. He will be based in BTIG’s New York office, and report to K.C. Stone, Managing Director and Head of BTIG Healthcare Investment Banking. BTIG continues to see a steady flow of healthcare banking activity and since 2020 the firm has participated in over 75 healthcare transactions.
Mr. Kleinberg has over 20 years of industry experience, most recently as a Managing Director within the Healthcare Investment Banking division at Truist, formerly SunTrust. Previously, he served as a Managing Director and the U.S. Head of Life Sciences Investment Banking at Fortis Bank, now part of BNP Paribas. Earlier in his career, Mr. Kleinberg was a Director of Healthcare Investment Banking at Ladenburg Thalmann and served in several positions including Managing Director within Healthcare Investment Banking at Gruntal.
“We are pleased to welcome Doug to our Healthcare Investment Banking unit,” commented Matt Clark, Managing Director and Head of BTIG Investment Banking. “He joins us at an exciting time where we are rapidly-expanding and diversifying our coverage team and universe. Doug’s specific expertise will be enormously valuable to our healthcare clients as they uncover opportunities in the marketplace.”
BTIG Investment Banking’s expertise spans the consumer, energy and infrastructure, financials, healthcare, real estate as well as technology, media and telecommunications sectors. The firm’s banking products include mergers and acquisitions, capital markets advisory, IPOs, follow-on offerings, ATMs, SPACs, private placements, convertibles, debt and corporate buybacks. Clients benefit from actionable market intelligence, and BTIG’s comprehensive understanding of financial dynamics. Aftermarket services include trading, corporate access, as well as proprietary research and strategy products.
“We are very excited to have Doug join BTIG Healthcare Investment Banking. His in-depth industry experience and impressive record of consistently positioning clients for success make him a welcome addition to our team,” noted Mr. Stone.
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 650 employees, BTIG, LLC and its affiliates operate out of 19 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.